cover image: The financial hardship of cancer in Canada

Premium

20.500.12592/dvhzq5

The financial hardship of cancer in Canada

31 Oct 2012

A Literature Review Purpose This literature review, initiated by Canadian Cancer Society Manitoba and the Canadian Cancer Action Network in November 2009, revised in August 2010 and again in July of 2011, seeks to gather evidence on the financial burden incurred by persons with cancer and their family in the treatment, survivor and palliative phases of the cancer journey. [...] In the Canadian Cancer Society’s (2009) Cancer Drug Access for Canadians report, the price tag of the average cost per course of treatment with newer cancer drugs is $65,000 and 3/4 of the new cancer drugs are taken at home, which means either the person with cancer or the insurance company must pay for it. [...] The role of caregiver to a child with cancer is different than that of a caregiver to a person in the palliative phase of the disease. [...] With a trend towards the deinstitutionalization of palliative care increasing and more people in the palliative phase of cancer wishing to spend their last days at home, the number of informal caregivers providing care to end-of-life patients is on the rise (Dumont et al., 2009; Grunfeld et al., 2004). [...] The responses from the caregivers make it clear that the length of the funding period needs to be increased and, given the challenges of predicting end-of-life, the requirement that the care recipient be within 6 months of death be more flexible (Williams et al., 2006).
health cancer employment health insurance labour medicine retirement neoplasms tumeurs unemployment health care disease socioeconomic factors therapy chemotherapy job salary breast cancer health treatment government health care caregiver facteurs socioéconomiques caregiving end-of-life care palliative cancéreux informal caregivers carer cancer survivor

Authors

Nelson, Colleen

Pages
35
Published in
Canada

Related Topics

All